Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
16.03
-0.51 (-3.08%)
Sep 20, 2024, 4:00 PM EDT - Market closed
Cartesian Therapeutics Employees
As of December 31, 2023, Cartesian Therapeutics had 38 total employees, including 37 full-time and 1 part-time employees.
Employees
38
Change
n/a
Growth
n/a
Revenue / Employee
$1,423,737
Profits / Employee
-$7,031,526
Market Cap
342.76M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 38 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| DocGo | 4,164 |
| Treace Medical Concepts | 516 |
| Poseida Therapeutics | 330 |
| Esperion Therapeutics | 240 |
| Voyager Therapeutics | 162 |
| AC Immune | 161 |
| Korro Bio | 102 |
| Jasper Therapeutics | 45 |
RNAC News
- 3 days ago - Cartesian Therapeutics Seems A 'Strong Buy' After Positive Phase 2 Results - Seeking Alpha
- 14 days ago - Cartesian Therapeutics Announces New Employment Inducement Grant - GlobeNewsWire
- 17 days ago - Cartesian Therapeutics Announces First Patient Dosed in First-In-Human Phase 1 Trial of Next-Generation mRNA CAR-T Cell Therapy Descartes-15 - GlobeNewsWire
- 6 weeks ago - Cartesian Therapeutics Announces New Employment Inducement Grants - GlobeNewsWire
- 2 months ago - Cartesian Therapeutics Strengthens Board of Directors with Appointment of Kemal Malik - GlobeNewsWire
- 2 months ago - Cartesian: Further Value To Be Unlocked After Positive MG Treatment Data - Seeking Alpha
- 2 months ago - Cartesian Therapeutics autoimmune disorder therapy meets main goal of mid-stage study - Reuters
- 2 months ago - Cartesian Therapeutics Announces $130 Million Private Placement Equity Financing - GlobeNewsWire